|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted deposits | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Loan to parent company | ||||||||||||||||||||
| Related parties | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| NON-CURRENT ASSETS | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Financial assets measured at cost method | ||||||||||||||||||||
| Investment in equity securities | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Non-current assets of discontinued operations | ||||||||||||||||||||
| Investments accounted for using the equity method | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Trade payables | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Government authorities | ||||||||||||||||||||
| Earn-out payable | ||||||||||||||||||||
| Short-term loans | ||||||||||||||||||||
| Current maturities of long-term loans | ||||||||||||||||||||
| Embedded derivatives | ||||||||||||||||||||
| Operating lease liabilities - short term | ||||||||||||||||||||
| Short-term convertible loans | ||||||||||||||||||||
| Related parties | ||||||||||||||||||||
| Other payables | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| NON-CURRENT LIABILITIES | ||||||||||||||||||||
| Long-term loans, net of current maturities | ||||||||||||||||||||
| Derivative warrant liability | ||||||||||||||||||||
| Operating lease liabilities - long term | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Non-current liabilities of discontinued operations | ||||||||||||||||||||
| Earn-out liability | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Common stock of $0.0001 par value - Authorized: 490,000,000 shares; Issued and outstanding: 18,829,198 and 10,670,392 shares as of June 30, 2026, and December 31, 2025, respectively. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Equity attributed to shareholders of Quantum X Labs Inc. | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
